Table of Contents

company-logo

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

Repare Therapeutics Dividend Announcement

• Repare Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Repare Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Repare Therapeutics Dividend History

Repare Therapeutics Dividend Yield

Repare Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Repare Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Repare Therapeutics Financial Ratios

P/E ratio-1.87
PEG ratio0.01
P/B ratio0.90
ROE-40.87%
Payout ratio0.00%
Current ratio6.45
Quick ratio6.45
Cash Ratio2.59

Repare Therapeutics Dividend FAQ

Does Repare Therapeutics stock pay dividends?
Repare Therapeutics does not currently pay dividends to its shareholders.
Has Repare Therapeutics ever paid a dividend?
No, Repare Therapeutics has no a history of paying dividends to its shareholders. Repare Therapeutics is not known for its dividend payments.
Why doesn't Repare Therapeutics pay dividends?
There are several potential reasons why Repare Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Repare Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Repare Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Repare Therapeutics a dividend aristocrat?
Repare Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Repare Therapeutics a dividend king?
Repare Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Repare Therapeutics a dividend stock?
No, Repare Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Repare Therapeutics stocks?
To buy Repare Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Repare Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.